Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1378 Discovery and characterization of PM-4321, a selective inhibitor of the aryl hydrocarbon receptor (AHR) with anti-tumor immunomodulatory effects
Compose a Response to This Article
Other responses
No responses have been published for this article.
